US 10729767
Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10729767 (Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage) held by Bioverativ USA Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bioverativ USA Inc.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/3955, A61P